DGAP-Adhoc: Biotest AG: Managing Board increases guidance

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: Biotest AG: Managing Board increases guidance 2013

Biotest AG / Key word(s): Change in Forecast 12.11.2013 09:00 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc RELEASE Announcement according to § 15 Sec. 1 Securities Trading Act (WpHG) Managing Board increases guidance 2013 Dreieich, 12 November 2013. The Managing Board of Biotest AG significantly raised the company's forecast for profit before interest and tax (EBIT) in the current year. The Management now expects a sales increase of 10% - 15% and an EBIT increase of 15% - 20%. Until now the EBIT increase had been forecasted with an increase of 10% - 15%. Biotest Aktiengesellschaft The Executive Management Board Biotest AG Landsteinerstr. 5 D-63303 Dreieich www.biotest.de Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and assets position of Biotest AG and its subsidiaries. These statements are based on current plans, estimates, forecasts and expectations of the company and are thus subject to risks and elements of uncertainty that could result in significant deviation of actual developments from expected developments. The forward-looking statements are only valid at the time of publication. Biotest does not intend to update the forward-looking statements and assumes no obligation to do so. About Biotest Biotest is a provider of plasma proteins and biotherapeutic drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the indications of rheumatoid arthritis and cancer of plasma cells, which are produced by recombinant technologies. Biotest has about 1.900 employees worldwide. The preference shares of Biotest AG are listed in the SDAX on the Frankfurt stock exchange. Securities' ID No., ISIN ordinary shares: 522720, DE0005227201 Securities' ID No., ISIN preference shares: 522723, DE0005227235 Listing: Prime Standard Open market: Berlin-Bremen, Düsseldorf, Frankfurt, Hamburg, Hannover, München, Stuttgart 12.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Biotest AG Landsteinerstra�e 5 63303 Dreieich Germany Phone: 0 61 03 - 8 01-0 Fax: 0 61 03 - 8 01-150 E-mail: investor_relations@biotest.de Internet: http://www.biotest.de ISIN: DE0005227235, DE0005227201 WKN: 522723, 522720 Indices: SDAX Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 17

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 28

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 30

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 29

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 18

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 26

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 25

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Action Initiated for Investors of Telix Pharmaceuticals Ltd.

Updated Category News Views 95

Class Action Lawsuit for Telix Pharmaceuticals Ltd. Investors Levi & Korsinsky, LLP has initiated a notification for investors in Telix Pharmaceuticals Ltd. The class action lawsuit aims to provide compensation for investors who have suffered losses. This action pertains to allegations of securities fraud impacting the company's reputation and financial integrity....

Continue Reading
Parcel Perform Elevates E-commerce Delivery with AI Decision Intelligence

Updated Category News Views 199

Revolutionizing E-commerce Delivery with AI In today’s landscape, AI is significantly altering the way consumers engage with e-commerce. Parcel Perform is at the forefront of this shift, urging businesses to 'Think Bigger on AI.' With Artificial Intelligence redefining the customer journey, a superior delivery experience has become paramount for success in online...

Continue Reading
Exploring New Innovations and Trends in China's Development

Updated Category News Views 321

Emerging Terms and Innovation from China's Latest Sessions In recent discussions, many revolutionary buzzwords have captured attention, signaling China’s aspirations for progress. New phrases like "funds and resources used to serve the people," "embodied AI," and "gazelle companies" reflect the ongoing transformation in sectors spanning government finance, technology,...

Continue Reading
Digital Realty Welcomes Paula Cogan as New EMEA Director

Updated Category News Views 265

Digital Realty Appoints Paula Cogan as Managing Director Digital Realty (NYSE: DLR), a leading global provider specializing in cloud- and carrier-neutral data center solutions, has announced the appointment of Paula Cogan as Managing Director and Head of the EMEA region. This strategic move is set to amplify Digital Realty’s growth in this essential market segment....

Continue Reading
Investors Urged to Act Before Deadline in DXC Class Action

Updated Category News Views 41

DXC Technology got hit with a class action lawsuit back in 2024 that sent ripples through the investor community. The Law Offices of Frank R. Cruz put out the call, reminding shareholders about an impending deadline to file a lead plaintiff motion. You buying DXC during the specified dates? You might wanna pay attention—this ain't just another legal shuffle. Financial...

Continue Reading